Human Papillomavirus Recombinant Vaccine from Japan
VLP vaccine from HPV L1 protein expression for cervical cancer prevention. Classified HTS 3002.49.0050 as other viral biotechnological product.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• List HPV types covered; 2-8°C with monitoring
• Pediatric/adult labeling; post-marketing commitment docs
• Bulk antigen to 3504 if unfinished